Sectra AB

SECT-B
stockHealthcareHealth Care TechnologyLinköping, Sweden
$6/day into SECT-B since 2015 would be worth $90,849 today — 5.3× the money.
Try your own number →

Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; and maintenance and consulting services. The Secure Communications segment develops and sells products and services for secure voice and data communications, and project-based development, as well as security and threat analyses, and system monitoring services for control systems. The Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; products for medical education and research projects; and IT support services for precision diagnostics in cancer care. It serves hospitals and private clinic chains. Sectra AB (publ) was incorporated in 1957 and is headquartered in Linköping, Sweden.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of SECTB-ST would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2004) — listing
$779,779
23.8×
$1,126,147
23.7×
Year 6 (2009)
$519,755
19.8×
$753,549
19.8×
Year 11 (2014)
$119,936
6.4×
$174,426
6.4×
Year 16 (2019)
$24,347
2.2×
$35,717
2.2×
Year 21 (2024)
$3,985
1.1×
$5,861
1.1×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Headquarters

Linköping, Sweden

Popular scenarios with SECT-B

https

For illustration only — not investment advice. Past performance is not indicative of future results.